Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate COVID-19: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
Michael G. Ison,Myra W Popejoy,Nikolay Evgeniev,M. Tzekova,Kathryn Mahoney,Natalia Betancourt,Yong Li,Deepali Gupta,Kristin Narayan,Ellie Hershberger,Lynn Connolly,Ilker Yalcin, Anita Das, J. R. Genge, M T D Smith,Ed Campanaro,Pamela Hawn,Pete Schmidt, Hiago Santos Soares Muniz,M. Tzekova, Kiril Palaveev, Vasil Tsenov, Liliya Pekova, Antoaneta Hadzhieva, Rumyana Mitreva, Nikolay Nikolaev, Elena Gyuzeleva, Marc Oliver Kornmann, Olaf Schmidt,Garyphalia Poulakou,Haralampos Milionis,Diamantis P. Kofteridis,Meletios Α. Dimopoulos, Ilias Skopelitis,Anastasia Kotanidou,Sotirios Tsiodras, Grzegorz Kania, Dagmara Grenik, Tomasz Zając,Anca Streinu‐Cercel,Larisha Pillay-Ramaya,Mohamed Mookadam,Lerato Mohapi, Johan Geldenhuys, Yacoob Vahed, C B S Bryce Holmgren, Martha Mekebeb-Reuter,William Brumskine, Daphne de Jong, Natasha Joseph, Kirsten McHarry, Shahid Wadvalla, Olena Kobrynska, I. V. Kireyev, Kyrylo Lebed, Pavlo Logoida, Ольга Василівна Барна,Olga Gyrina, Bogdan Gundertaylo, В. В. Родіонова
Open Forum Infectious Diseases (2023)
Cited2Views0Bibtex
2
0
Load More
Author Statistics

#Papers: 32

#Citation: 2927

H-Index: 14

G-Index: 24

Sociability: 5

Diversity: 2

Activity: 3

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn